Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Alligator Bioscience
Alligator Bioscience
Activities:
Regulatory
Research & Development
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Aptevo and Alligator Bioscience develop immunotherapy candidate
Aptevo Therapeutics and Alligator Bioscience begin investigational new drug development to investigate the bispecific immunotherapy candidate ALG.APV-527
Ingredients
Cobra Biologics and Alligator Bioscience extend drug development partnership
Project will deliver second cell line to manufacture immuno-oncology antibody ADC-1015 following ADC-1013 success
Research & Development
J&J announces immuno-oncology collaboration with Alligator Bioscience
Alligator will complete the current Phase I study and Janssen will be responsible for all subsequent product development
Ingredients
Alligator Bioscience benefits from Cobra’s maxXpress platform
Cobra developed the cell line to express agonistic CD40 antibodies for an immuno-oncology application using its maxXpress platform
Manufacturing
Cobra to produce monoclonal antibody products for Alligator
Will provide cell line development, scale-up, GMP supplies and stability studies
Subscribe now